These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 16227166

  • 1. Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer.
    Salminen E, Ala-Houhala M, Korpela J, Varpula M, Tiitinen SL, Halleen JM, Väänänen HK.
    Acta Oncol; 2005; 44(7):742-7. PubMed ID: 16227166
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Serum TRACP 5b and ICTP as markers of bone metastases in breast cancer.
    Korpela J, Tiitinen SL, Hiekkanen H, Halleen JM, Selander KS, Väänänen HK, Suominen P, Helenius H, Salminen E.
    Anticancer Res; 2006; 26(4B):3127-32. PubMed ID: 16886645
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
    Terpos E, de la Fuente J, Szydlo R, Hatjiharissi E, Viniou N, Meletis J, Yataganas X, Goldman JM, Rahemtulla A.
    Int J Cancer; 2003 Sep 01; 106(3):455-7. PubMed ID: 12845688
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay.
    Wu ZQ, Zhang Y, Xie E, Song WJ, Yang RX, Yan CJ, Zhang BF, Xu HG.
    PLoS One; 2016 Sep 01; 11(1):e0147554. PubMed ID: 26800211
    [Abstract] [Full Text] [Related]

  • 11. Serum tartrate resistant acid phosphatase as a potential marker of bone metastasis from breast cancer.
    Wada N, Ishii S, Ikeda T, Enomoto K, Kitajima M.
    Anticancer Res; 1999 Sep 01; 19(5C):4515-21. PubMed ID: 10650803
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.
    Chao TY, Wu YY, Janckila AJ.
    Clin Chim Acta; 2010 Nov 11; 411(21-22):1553-64. PubMed ID: 20599857
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients.
    Yao NS, Wu YY, Janckila AJ, Ku CH, Hsieh AT, Ho CL, Lee SH, Chao TY.
    Clin Chim Acta; 2011 Jan 14; 412(1-2):181-5. PubMed ID: 20932965
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases.
    Wakabayashi H, Nakajima K, Mizokami A, Namiki M, Inaki A, Taki J, Kinuya S.
    Ann Nucl Med; 2013 Nov 14; 27(9):802-7. PubMed ID: 23828554
    [Abstract] [Full Text] [Related]

  • 20. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
    Tähtelä R, Seppänen J, Laitinen K, Katajamäki A, Risteli J, Välimäki MJ.
    Osteoporos Int; 2005 Sep 14; 16(9):1109-16. PubMed ID: 15605190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.